The short version of GHRH receptor fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-11-08 and is reviewed periodically as new material appears.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
June 4: Tiananmen Square Massacre: Beijing protests are crushed by the communist Chinese government, resulting in an unknown number of deaths. June 4: Elections in Poland show complete lack of backing for the Communist Party; Solidarity trade union wins all available seats in the Parliament and 99% in the Senate. August 19: The opening of the border gate between Austria and Hungary at the Pan-European Picnic set in motion a chain reaction, at the end of which there was no longer a GDR and the Eastern Bloc had disintegrated. August 23: Baltic Way: independence protesters in Estonia, Latvia and Lithuania set up a human chain across the three Baltic states, from Tallinn to Vilnius via Riga. August: Parliament in Poland elects Tadeusz Mazowiecki as leader of the first non-communist government in the Eastern Bloc. October 7: Hungarian Socialist Workers' Party, the ruling party of Hungary, is dissolved. October 18: The Hungarian constitution is amended to allow a multi-party political system and elections. In East Germany, the nearly 20-year term of communist leader Erich Honecker comes to an end. November 7: Civil unrest occurred in Moldova. November 9: Revolutions of 1989: Soviet reforms have allowed Eastern Europe to change the Communist governments there. The Berlin Wall is breached when Politburo spokesman, Günter Schabowski, not fully informed of the technicalities or procedures of the newly agreed lifting of travel restrictions, mistakenly announces at a news conference in East Berlin that the borders have been opened.
Some sperm banks enable recipients to choose the sex of their child, through methods of sperm sorting. Although the methods used do not guarantee 100% success, the chances of being able to select the gender of a child are held to be considerably increased. Sex selection is controversial, and is illegal in many countries, including Australia, the United Kingdom, and Canada, except when there is a large possibility of a sex-linked genetic disorder. It is legal in the United States, although use for non-medical reasons is discouraged by the American Society for Reproductive Medicine.
A variety of mechanisms act to ensure that the digestive action of the pancreas does not act to digest pancreatic tissue itself. These include the secretion of inactive enzymes (zymogens), the secretion of the protective enzyme trypsin inhibitor, which inactivates trypsin, the changes in pH that occur with bicarbonate secretion that stimulate digestion only when the pancreas is stimulated, and the fact that the low calcium within cells causes inactivation of trypsin.
Sources: en.wikipedia.org
Structure/function analysis established that a fusion protein containing Cut domains 1 and 2 linked to a nuclear localization signal (C1C2-NLS) is rapidly recruited to DNA damage and is sufficient to accelerate the repair oxidative DNA damage and mono-alkylated bases in genomic DNA. Since the C1C2-NLS protein is devoid of transcription activation potential, these results suggest that Cut domains are directly involved in DNA repair.
cuvette A type of small container used in spectroscopy experiments, usually made of plastic, glass, or quartz and designed to hold a sample (typically a liquid) for measurement inside a spectrometer. Cuvettes should be as clean and transparent as possible to minimize interference with the beams of light on which spectroscopic techniques rely.
=== Awards and honours === Knowles was elected a Fellow of the Royal Society (FRS), a Fellow of the American Academy of Arts and Sciences (FAAAS) in 1982, and member of American Philosophical Society in 1988, the American Association for the Advancement of Science, and a Foreign Associate of the National Academy of Sciences. Among his awards are the Royal Society of Chemistry's Charmian Medal, the Bader Award, the Repligen Corporation Award in Chemistry of Biological Processes, the Prelog Medal, the Robert A. Welch Award in Chemistry, the Arthur C. Cope Scholar Award, and the Nakanishi Prize. He was awarded the Davy Medal of the Royal Society, and was an Honorary Fellow of Balliol College and of Wadham College, Oxford. He held honorary degrees from the University of Edinburgh and the Eidgenössische Technische Hochschule in Zürich. He was appointed Order of the British Empire in the 1993 Birthday Honours. He was elected one of nine Trustees of the Howard Hughes Medical Institute in 1998.
Sources: en.wikipedia.org
== Management == Management focuses on reducing cardiovascular and metabolic risk through lifestyle modification, pharmacologic therapy, and, in selected cases, surgery. Because metabolic syndrome represents a cluster of interrelated conditions, treatment typically targets each component individually rather than the syndrome as a single entity. Lifestyle modification is the cornerstone of management of metabolic syndrome. A randomized control trial of 618 adults with metabolic syndrome evaluated an intensive lifestyle modification conducted over six months to encourage increased vegetable intake, brisk walks, sensory awareness, and emotion regulation, compared with a control intervention of monthly educational mailings. Members of the intervention group were ~33% more likely to experience remission of metabolic syndrome.
On 1 July, the experiment was performed with fifty mice, half of whom received penicillin. All twenty-five of the control mice died within sixteen hours while all but one of the treated mice were alive ten days later. Over the following weeks they performed experiments with batches of 50 or 75 mice, but using different bacteria. They found that penicillin was also effective against staphylococci and gas gangrene. Florey reminded his staff that promising as their results were, a human being weighed 3,000 times as much as a mouse. The Oxford team reported their results in the 24 August 1940 issue of The Lancet, a prestigious medical journal, as "Penicillin as a Chemotherapeutic Agent" with names of the seven joint authors listed alphabetically. They concluded:
All travel center locations include a bakery, a brisket station, a fudge bar, snack aisle, soda, coffee, and an Icee station. Stores have various candy and beef jerky flavors to purchase. Product offerings include cookies, kolaches (Czech pastries), and other pastries in the bakery, BBQ brisket sandwiches, chicken sandwiches, and breakfast tacos/bowls/burritos/sandwiches at the brisket bar along with cold-cut wraps and sandwiches. Packaged cups of fruit, vegetables, and desserts can be purchased as well. Locations also house packaged general snack foods like nuts and fudge, ice cream and Dippin' Dots, water, soda, energy drinks, and alcoholic drinks. The company has produced many of its own original snack foods including Beaver chips, potato chips made on site. The most distinctive snack are "Beaver Nuggets" (flavored corn puff snacks), the company's best-selling product.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.